Rachel Haurwitz Biography

Rachel Haurwitz is a biotech entrepreneur and the CEO of Caribou Biosciences, a company focused on gene editing technology. She co-founded Caribou Biosciences in 2011 while completing her Ph.D. in Jennifer Doudna's lab at UC Berkeley. Under her leadership, Caribou Biosciences has become a leading company in the field of CRISPR gene editing, with a strong focus on developing therapies for genetic diseases. Haurwitz has been recognized for her work in biotechnology, including being named a Forbes 30 Under 30 in Science in 2015 and Fortune's 40 Under 40 in Health list in 2019. She has also been a speaker at various conferences and events, including the Wired Health Conference and the Milken Institute Global Conference. In addition to her work with Caribou Biosciences, Haurwitz is a member of the Board of Directors for the American Society of Gene and Cell Therapy and is an active investor in other biotech companies. She is also a co-author of the book "A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution," which explores the science and ethics of gene editing.

As a renowned expert and highly sought-after speaker, Rachel Haurwitz's expertise is in high demand. To book Rachel Haurwitz for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Rachel Haurwitz's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Rachel Haurwitz's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Rachel Haurwitz for your next speaking engagement.